Despite the benefits of continuous processing adoption has been slow, except for a few process areas.
Kathleen A. Estes
Advertisement
Kathleen A. Estes, PhD, is director of research communications atBioPlan Associates, Inc. She is an experienced market research and data trends analyst, author, and editor, kestes@bioplanassociates.com.
Articles by Kathleen A. Estes
Although widespread adoption of continuous bioprocessing has been slow, some processes have been an exception.
Advertisement
Latest Updated Articles
Update on Continuous Bioprocessing: From the Industry’s Perception to RealityPublished: June 2nd 2017 | Updated:
- Overcoming Concerns to Adopting Continuous Processes
Published: July 5th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
AAPS PharmSci 360 2025: Trends in Bioanalysis
3
PharmTech Weekly News Roundup – Week of November 3, 2025
4
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
5
